Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BTX:US

4.5800 USD 0.0800 1.78%

As of 20:04:03 ET on 05/21/2015.

Snapshot for BioTime Inc (BTX)

Open: 4.5200 Day's Range: 4.4300 - 4.6000 Volume: 222,719
Previous Close: 4.5000 52wk Range: 2.2900 - 5.9500 1-Yr Rtn: +95.73%

Stock Chart for BTX

No chart data available.
  • BTX:US 4.5800
  • 1D
  • 1M
  • 1Y
4.5000
Interactive BTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.5517
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 381.36
Shares Outstanding (M) 83.27
30 Day Average Volume 401,151
Price/Book (mrq) 15.7664
Price/Sale (ttm) 60.3416
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BTX

BioTime, Inc. researches and develops synthetic solutions that can be used as blood plasma volume expanders, blood replacement solutions during hypothermic surgery, and organ preservation solutions. The Company also operates in regenerative medicine sector, where it develops stem cell related products and technology for diagnostic, therapeutic and research use.

Michael D WestChief Executive OfficerAditya MohantyChief Operating Officer
Lesley A StolzExec VP:Corporate DevelopmentRobert W PeabodySenior VP/CFO
More Company Profile & Key Executives for BTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil